MX2024010387A - Formulaciones que comprenden polimero neutralizante de acido para administracion oral de agentes activos. - Google Patents

Formulaciones que comprenden polimero neutralizante de acido para administracion oral de agentes activos.

Info

Publication number
MX2024010387A
MX2024010387A MX2024010387A MX2024010387A MX2024010387A MX 2024010387 A MX2024010387 A MX 2024010387A MX 2024010387 A MX2024010387 A MX 2024010387A MX 2024010387 A MX2024010387 A MX 2024010387A MX 2024010387 A MX2024010387 A MX 2024010387A
Authority
MX
Mexico
Prior art keywords
formulations
acid
oral administration
active agents
polymer
Prior art date
Application number
MX2024010387A
Other languages
English (en)
Spanish (es)
Inventor
Gregory Burshtein
Phillip M Schwartz
Hillel Galitzer
Constantin Itin
Original Assignee
Entera Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entera Bio Ltd filed Critical Entera Bio Ltd
Publication of MX2024010387A publication Critical patent/MX2024010387A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2024010387A 2022-02-24 2023-02-23 Formulaciones que comprenden polimero neutralizante de acido para administracion oral de agentes activos. MX2024010387A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263313363P 2022-02-24 2022-02-24
PCT/IL2023/050192 WO2023161934A1 (en) 2022-02-24 2023-02-23 Formulations comprising acid-neutralizing polymer for oral administration of active agents

Publications (1)

Publication Number Publication Date
MX2024010387A true MX2024010387A (es) 2024-09-04

Family

ID=87765060

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024010387A MX2024010387A (es) 2022-02-24 2023-02-23 Formulaciones que comprenden polimero neutralizante de acido para administracion oral de agentes activos.

Country Status (10)

Country Link
US (1) US20250186558A1 (cg-RX-API-DMAC7.html)
EP (1) EP4482507A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025506821A (cg-RX-API-DMAC7.html)
KR (1) KR20240152915A (cg-RX-API-DMAC7.html)
CN (1) CN119053335A (cg-RX-API-DMAC7.html)
AU (1) AU2023226618A1 (cg-RX-API-DMAC7.html)
CA (1) CA3251862A1 (cg-RX-API-DMAC7.html)
IL (1) IL315198A (cg-RX-API-DMAC7.html)
MX (1) MX2024010387A (cg-RX-API-DMAC7.html)
WO (1) WO2023161934A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025046589A1 (en) * 2023-08-30 2025-03-06 Entera Bio Ltd. Formulations comprising a combination of acid-neutralizing polymeric and non-polymeric substances for oral administration of active agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5175553B2 (ja) * 2005-02-01 2013-04-03 エミスフェアー・テクノロジーズ・インク 胃内滞留および制御放出型送達系
WO2008070543A1 (en) * 2006-12-01 2008-06-12 Emisphere Technologies Inc. Improved acyclovir formulations
US20090124639A1 (en) * 2007-11-06 2009-05-14 Emisphere Technologies Inc. valacyclovir formulations
WO2016128972A1 (en) * 2015-02-09 2016-08-18 Entera Bio Ltd. Formulations for oral administration of active agents with controlled absorption profile
MX2019001850A (es) * 2016-08-17 2019-05-15 Entera Bio Ltd Formulaciones para administracion oral de principios activos.
WO2018121702A1 (zh) * 2016-12-30 2018-07-05 江苏恒瑞医药股份有限公司 一种glp-1类似物的药物组合物及其制备方法
CN112587496A (zh) * 2020-12-16 2021-04-02 江苏海洋大学 一种艾塞那肽肠溶胶囊及其制备方法

Also Published As

Publication number Publication date
JP2025506821A (ja) 2025-03-13
CN119053335A (zh) 2024-11-29
WO2023161934A1 (en) 2023-08-31
EP4482507A1 (en) 2025-01-01
IL315198A (en) 2024-10-01
US20250186558A1 (en) 2025-06-12
EP4482507A4 (en) 2026-02-18
CA3251862A1 (en) 2023-08-31
AU2023226618A1 (en) 2024-10-03
KR20240152915A (ko) 2024-10-22

Similar Documents

Publication Publication Date Title
US6790867B2 (en) Compositions and method for treating infection in cattle and swine
AU622756B2 (en) Compositions and method for the treatment of periodontal disease
US6239119B1 (en) Topical administration of amifostine and related compounds
IL274058A (en) Treatment of inflammatory lesions of rosacea with ivermectin
EP1267826B1 (en) Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion
WO2013013143A1 (en) Fixed dose combination of bimatoprost and brimonidine
MX2024010388A (es) Formulaciones que comprenden un polimero neutralizante de acido para la administracion oral del peptido-1 similar al glucagon y sus analogos.
MX2024010389A (es) Formulaciones que comprenden un polimero neutralizante de acido para la administracion oral de hormona paratiroidea.
AU645359B2 (en) Lithium treatment
JPH10509463A (ja) 炎症反応に起因する哺乳類の疾病の治療方法およびその組成物
US20050214230A1 (en) Novel stomatological gel
MX2024010386A (es) Formulaciones que comprenden un polimero neutralizante de acido para la administracion oral de peptido-2 que es similar al glucagon
KR20230047412A (ko) 진통 가려움 완화 약학 조성물 및 그 응용 방법
RU2205011C1 (ru) Фармацевтическая композиция с антибактериальной активностью
CN112996488B (zh) 唑吡坦或其药学上可接受的盐的口粘膜溶液
RU2398589C1 (ru) Средство "экспортал", обладающее гастропротективным (противоязвенным) действием
US20070092583A1 (en) Cold remedy composition comprising zinc salts
EP1875913A1 (en) Compositions and method for treating infection in cattle and swine
Beech Drug therapy of respiratory disorders
JPH0662442B2 (ja) 点鼻薬
WO2024151969A1 (en) Potassium channel blockers or derivatives thereof for preventing, alleviating, and/or treating morbidity and mortality induced by pathogens or other inducers of immune exhaustion and/or excess immune activation
CN120000645A (zh) 白塞综合征的治疗
RU2024127834A (ru) Композиции, содержащие кислотонейтрализующий полимер для перорального введения паратиреоидного гормона
TR201723198A2 (tr) Erdostein ve askorbik asit ihtiva eden kompozisyonlar.
MX9605497A (es) Composicion para tratamiento en enfermedades inflamatorias cronicas.